Creatine and Resistance Training: What the Evidence Says

Creatine and Resistance Training has 5 source documents in the current Migaku evidence database. The strongest available sources in this first pass are system

6 min read · 1,162 wordsReviewed June 2026
Focused athlete preparing to lift a heavy barbell. Indoor gym setting. - Evidence evidence guide for creatine supplementation resistance training
Photo by Victor Freitas on Pexels · Pexels License

Quick Answer

Creatine and Resistance Training has 5 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 4 systematic review, 1 narrative review.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Evidence ladder

How To Read Creatine Evidence

Level 1: Strongest
Systematic reviews and meta-analyses

Useful for broad patterns in strength, lean mass, and training context.

Level 2: Helpful
Randomized resistance-training studies

Useful when population, dose, duration, and outcome match the reader question.

Level 3: Supportive
Narrative reviews and mechanisms

Good for background, not enough for product-specific promises.

Level 4: Weakest
Marketing claims and isolated anecdotes

Do not use for rankings unless supported by independent evidence.

Creatine and Resistance Training: What the Evidence Says

Quick Answer

Creatine and Resistance Training has 5 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 4 systematic review, 1 narrative review.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Correction: Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass systematic review 1 2026-05-20 10.3389/fnut.2026.1854605
Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis systematic review 1 2026-05-16 10.1080/15502783.2026.2668435
Does creatine affect lipid profile? a systematic review and meta-analysis of randomized placebo-controlled trials systematic review 1 2026-05-08 10.3389/fnut.2026.1787009
Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass systematic review 1 2026-04-08 10.3389/fnut.2026.1800546
The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications narrative review 3 2026-03-23 10.1080/15502783.2026.2646627

What The Sources Report

  • These studies have been removed, and the affected PRISMA flow diagram, study-characteristics table, risk-of-bias summary, outcome analyses, subgroup analyses, GRADE table, figures, and supplementary files have been updated accordingly. [Gu Jinfa (2026); evidence level 1]
  • Theandsections of the abstract have been corrected to read: This systematic review and meta-analysis pooled RCT evidence in healthy men aged 18-30 years old to quantify the effects of creatine supplementation in terms of body composition, maximal strength, and exercise performance. [Gu Jinfa (2026); evidence level 1]
  • These changes contribute to increased sarcopenia risk during and after the menopausal transition, with implications for physical function, frailty, and long-term musculoskeletal health. [Naddafha Siavash (2026); evidence level 1]
  • In addition, creatine may exert direct anabolic or anticatabolic effects on muscle cells and influence bone via increased muscle pulling forces or direct cell signaling in osteoblasts. [Naddafha Siavash (2026); evidence level 1]
  • The scientific community has responded with growing scrutiny of extraordinary health and weight-loss promises that lack robust evidence, reinforcing the need for critical appraisal and public clarification regarding risks and benefits. [Gimenez Fabiana V. M. (2026); evidence level 1]
  • Despite strong evidence supporting its ergogenic effects, misconceptions persist, including beliefs that creatine causes excessive water retention, kidney damage, baldness, muscle cramping, dehydration, steroid-like effects, or fat gain. [Gimenez Fabiana V. M. (2026); evidence level 1]
  • Creatine is an inborn nitrogen-containing compound, of which approximately 95% is present in the skeletal muscle; smaller quantities are found in tissues such as the brain, myocardium, and testes. [Gu Jinfa (2026); evidence level 1]
  • Several systematic reviews and meta-analyses have found modest increases in lean body mass or fat-free mass; however, some have also found large between-study variability. [Gu Jinfa (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For creatine supplementation resistance training, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Bottom Line For Readers

For creatine and resistance training, this knowledge-base sample includes at least one stronger evidence source. One representative source-reported claim is: "These studies have been removed, and the affected PRISMA flow diagram, study-characteristics table, risk-of-bias summary, outcome analyses, subgroup analyses, GRADE table, figures, and supplementary files have been updated accordingly." The safest editorial posture is to focus on resistance-training contexts, lean mass or performance outcomes, and study population details.

Evidence Strength

The current evidence set includes 5 unique source documents. 4 sources are level 1-2 in this system, while 1 source is lower-level, indirect, narrative, or early-stage evidence. Treat this as a structured reading guide rather than a final clinical guideline.

What This Means In Practice

  • Tie claims to resistance training, population, and measured outcomes such as lean mass, strength, or repeated effort.
  • Distinguish creatine monohydrate evidence from claims about newer or branded forms.
  • Keep safety language conservative for people with kidney disease, medications, pregnancy, or adolescent use.

What The Evidence Does Not Prove

  • It does not prove the same benefit for every age group, sex, training status, sport, or dose.
  • It does not justify product-specific claims unless product quality and formulation evidence are separately reviewed.

Editorial Use Cases

This page is most useful as a citation hub for answer-first pages about creatine and resistance training. It can support cautious explainers, comparison sections, safety notes, and evidence tables. It should not be used alone to rank products, promise outcomes, or replace condition-specific clinical guidance.

Limits Of This First Pass

This deep evidence page is still generated from a bounded knowledge-base sample. It should be reviewed by a human editor before being used for high-stakes decisions or product-ranking claims.

References

  • Gu Jinfa (2026). Correction: Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass. DOI: 10.3389/fnut.2026.1854605. PMCID: PMC13231500. PMID: 42245548. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13231500/
  • Naddafha Siavash (2026). Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. DOI: 10.1080/15502783.2026.2668435. PMCID: PMC13182165. PMID: 42141930. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13182165/
  • Gimenez Fabiana V. M. (2026). Does creatine affect lipid profile? a systematic review and meta-analysis of randomized placebo-controlled trials. DOI: 10.3389/fnut.2026.1787009. PMCID: PMC13194357. PMID: 42180567. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13194357/
  • Gu Jinfa (2026). Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass. DOI: 10.3389/fnut.2026.1800546. PMCID: PMC13099317. PMID: 42027564. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13099317/
  • Kerksick Chad (2026). The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications. DOI: 10.1080/15502783.2026.2646627. PMCID: PMC13011109. PMID: 41870601. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13011109/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed June 10, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →